Browsing Tag
Boots
2 posts
SkinBioTherapeutics (LSE: SBTX) is growing again, but will cash last long enough?
SkinBioTherapeutics is growing revenue, but cash and credibility remain tight. New FY2026 guidance will decide whether SBTX can rerate.
July 10, 2026
Legal & General announces £4.8bn buy-in with Boots Pension Scheme
Legal & General Group plc, a renowned financial services firm, has achieved a significant milestone by finalizing a…
November 26, 2023